| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/23/2006 | EP1692179A1 An antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the same |
| 08/23/2006 | EP1692178A1 Methods and compositions for inhibiting c-met dimerization and activation |
| 08/23/2006 | EP1692177A2 Antibodies that specifically bind pms2 |
| 08/23/2006 | EP1692176A1 Anti-igf-i receptor antibody |
| 08/23/2006 | EP1692174A2 Monkey immunoglobulin sequences |
| 08/23/2006 | EP1692166A1 Novel muscle growth regulator |
| 08/23/2006 | EP1692102A2 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 08/23/2006 | EP1691845A1 Compounds containing matrix metalloproteinase substrates and methods of their use |
| 08/23/2006 | EP1691840A2 Psma formulations and uses thereof |
| 08/23/2006 | EP1691837A2 Ip-10 antibodies and their uses |
| 08/23/2006 | EP1691836A2 Anti-pecam therapy for metastasis suppression |
| 08/23/2006 | EP1691835A1 Methods of treating chronic pain using compositions that specifically bind cd11d (alpha-d) integrin |
| 08/23/2006 | EP1691833A2 Compositions comprising polypeptides |
| 08/23/2006 | EP1691832A2 Immunoglobulins whith potent and broad antiviral activity |
| 08/23/2006 | EP1691824A2 Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 08/23/2006 | EP1691799A2 Lipid rafts and clostridial toxins |
| 08/23/2006 | EP1691763A2 Cab molecules |
| 08/23/2006 | EP1691664A2 Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof |
| 08/23/2006 | EP1499896B1 Method for diagnosing neoplasms |
| 08/23/2006 | EP1358318B1 Hybridoma cell line g250 and its use for producing monoclonal antibodies |
| 08/23/2006 | EP1334122B1 Nucleic acids encoding stichodactylidae chromoproteins |
| 08/23/2006 | EP1240337B1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 08/23/2006 | EP1178824B1 Staphylococcus aureus antigen-containing whole cell vaccine |
| 08/23/2006 | EP1062346B1 Gene encoding labyrinthin, a marker for cancer |
| 08/23/2006 | EP1012181B1 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
| 08/23/2006 | CN1823274A Method for diagnosing endometriosis-related disease in womb |
| 08/23/2006 | CN1823164A A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire |
| 08/23/2006 | CN1823163A Antibodies against insulin-like growth factor i receptor and uses thereof |
| 08/23/2006 | CN1822857A De-immunized anti-CD3 antibody |
| 08/23/2006 | CN1821404A Rabbit anti-human CIDE-3 protein poly clonal antibody |
| 08/23/2006 | CN1821401A Method for obtaining functional protein fragment with independent structure |
| 08/23/2006 | CN1821273A Anti-human marrow mesenchymal stem cell monoclonal antibudy ZUB4 and use |
| 08/23/2006 | CN1821272A Anti-human marrow mesenchymal stem cell monoclonal antibody ZUE12 and use |
| 08/23/2006 | CN1820734A Treatment with anti-erbb2 antibodies |
| 08/23/2006 | CN1271210C Neutralization monoclonal antibody of white spot syndrome virus and preparation method |
| 08/23/2006 | CN1271205C Reconstituted human anti-HM1.24 antibody |
| 08/23/2006 | CN1270775C Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enbancing agents |
| 08/23/2006 | CN1270774C Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 08/22/2006 | US7094887 UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R(GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2GnT3 |
| 08/22/2006 | US7094883 Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein |
| 08/22/2006 | US7094882 Growth factor which acts through erb b-4 rtk |
| 08/22/2006 | US7094881 For diagnosis and therapy |
| 08/22/2006 | US7094877 Protein for use in treatment of inflammation, nervous system, pain, arthritic and skin disorders |
| 08/22/2006 | US7094876 Human cDNAs and proteins and uses thereof |
| 08/22/2006 | US7094874 Soluble CTLA4 mutant molecules |
| 08/22/2006 | US7094869 Animal growth regulators |
| 08/22/2006 | US7094750 Toxin for use in treating cancer; antitumor agents |
| 08/22/2006 | US7094597 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 08/22/2006 | US7094579 Providing a culture of bacterial cells, adding rhanmose to the culture to induce rhamnose promoter whereby the antibody heavy chain and light chain and their linked signal sequences are expressed, secreted to the periplasm |
| 08/22/2006 | US7094578 α1,2 fucosyltransferase |
| 08/22/2006 | US7094577 Insulin and albumin fusion protein |
| 08/22/2006 | US7094576 Detecting helminth infection using synthetic larval proteins; immunoassay; parasiticides |
| 08/22/2006 | US7094572 Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74 |
| 08/22/2006 | US7094556 Diagnosis and treatment of malignant neoplasms |
| 08/22/2006 | US7094554 Cry proteins; for crop growth and development; pesticides |
| 08/22/2006 | US7094553 Can be used in an assay to determine if a sample is infected with infectious prions, i.e. PrPSc |
| 08/22/2006 | US7094551 Immunoassays, assay methods, antibodies and method of creating antibodies for detecting FGF-23 |
| 08/22/2006 | US7094550 Diagnosing atherosclerosis in humans; obtain blood, incubate with confining complex, detect signal from bound complex, evaluate for atherosclerosis |
| 08/22/2006 | US7094549 mass spectroscopy; medical diagnosis/prognosis; kits |
| 08/22/2006 | US7094547 Sperm specific proteins |
| 08/22/2006 | US7094409 Antigen arrays for treatment of allergic eosinophilic diseases |
| 08/22/2006 | US7094406 Enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof |
| 08/22/2006 | US7094403 Mycobacterium tuberculosis superoxide dismutase |
| 08/22/2006 | US7094402 Polynucleotides (with nucleotide sequence operably linked to an expression control sequence) encoding the human IL-11 receptor and fragments |
| 08/17/2006 | WO2006086716A2 Donor lymphocyte infusion of activated t cells for the treatment of cancer |
| 08/17/2006 | WO2006086469A2 Antibodies to tgfbeta |
| 08/17/2006 | WO2006085961A2 Anti-mcp-1 antibodies, compositions, methods and uses |
| 08/17/2006 | WO2006085938A2 Il-13 binding agents |
| 08/17/2006 | WO2006085918A2 Rabbit monoclonal antibodies to hepatitis b surface antigens and methods of using the same |
| 08/17/2006 | WO2006085913A2 Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof |
| 08/17/2006 | WO2006085822A1 Site-specific immunization in order to establish antibodies with specificity for the e7 oncoprotein of high-risk hpvs |
| 08/17/2006 | WO2006085749A1 Plant virus designated tomato torrado virus |
| 08/17/2006 | WO2006085648A1 Novel narcolepsy-related gene |
| 08/17/2006 | WO2006085553A1 Anti-tlr6 antibody and utilization of the same |
| 08/17/2006 | WO2006085518A1 Method for improving antibody |
| 08/17/2006 | WO2006085441A1 Antibody for assay of adamts13 activity and method of activity assay |
| 08/17/2006 | WO2006085092A2 Methods and uses of antibodies in the purification of interferon |
| 08/17/2006 | WO2006084758A1 Human monoclonal antibody specific for lipopolysaccharides (lps) of the pseudomonas aeruginosa iats o11 serotype |
| 08/17/2006 | WO2006084466A2 Surface-located streptococcus pneumoniae polypeptides |
| 08/17/2006 | WO2006071280B1 Immunoglobulins comprising predominantly a ga1g1cnacman5glcnac2 glycoform |
| 08/17/2006 | WO2006068975A3 Binding proteins specific for human matriptase |
| 08/17/2006 | WO2006061650A3 Methods, products and uses involving platelets and/or the vasculature |
| 08/17/2006 | WO2006056031A8 Use of ferrous ions for increasing the immunoreactivity of immunoglobulin preparations |
| 08/17/2006 | WO2006055974A3 Method of treating diseases and disorders |
| 08/17/2006 | WO2006046042A3 Method of selecting polypeptides |
| 08/17/2006 | WO2006042173A3 Modulators of hepatocyte growth factor activator |
| 08/17/2006 | WO2006039135A3 Irta-4 antibodies and their uses |
| 08/17/2006 | WO2006023144A3 Look-through mutagenesis for developing altered polypeptides with enhanced properties |
| 08/17/2006 | WO2005111072A3 Notch-based fusion proteins and uses thereof |
| 08/17/2006 | WO2005106039A8 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 08/17/2006 | WO2005089813A3 Receptor-avid exogenous optical contrast and therapeutic agents |
| 08/17/2006 | WO2005049814A3 Novel atypical pneumonia-causing virus |
| 08/17/2006 | WO2005021713A3 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using |
| 08/17/2006 | WO2004089284A8 Targets for tumor growth inhibition |
| 08/17/2006 | WO2004067553A3 Tolerance-induced targeted antibody production |
| 08/17/2006 | WO2003104391A3 Antibacterial targets in alloiococcus otitidis |
| 08/17/2006 | WO2003087124A3 Hmgn2 peptides and related melecules that selectively home to tumor blood vessels and tumor cells |
| 08/17/2006 | WO2003075860A3 Detection and modulation of slit and roundabount (robo) mediated angiogenesis and uses thereof |
| 08/17/2006 | WO2003047510A3 Anti-tnf antibodies, compositions, methods and uses |
| 08/17/2006 | US20060185026 Atypical protein kinase c isoforms in disorders of the nervous system and cancer |